NCT02251613View on ClinicalTrials.gov

Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Olopatadine HCl ophthalmic solution, 0.1%

DRUG

Epinastine HCl ophthalmic solution, 0.05%

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT02251613 - Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan | Biotech Hunter | Biotech Hunter